Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Grant or award Director acquired 1,738 shares (grant or award)
  2. 4 Grant or award SEE REMARKS acquired 15,639 shares (grant or award)
  3. 4 Grant or award Director acquired 1,640 shares (grant or award)
  4. 4 Grant or award Director acquired 2,197 shares (grant or award)
  5. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 14,736 shares (grant or award)
  6. 4 Grant or award Director acquired 69,784 shares (grant or award)
  7. 4 Grant or award SEE REMARKS acquired 17,916 shares (grant or award)
  8. 4 Grant or award SEE REMARKS acquired 21,158 shares (grant or award)
  9. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 71,715 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Grant or award CHIEF BUSINESS OFFICER acquired 9,525 shares (grant or award)
  17. 4 Open-market sale SEE REMARKS sold 60 shares at $28.55 ($1,713)
  18. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 60 shares at $28.54 ($1,712)
  19. 4 Open-market sale SEE REMARKS sold 73 shares at $28.53 ($2,083)
  20. 4 Open-market sale SEE REMARKS sold 62 shares at $28.54 ($1,769)

Page 5 of 15 · 288 filings